{
    "organizations": [],
    "uuid": "177f9b271fa23815e546887f8ba63e250bcd986e",
    "author": "",
    "url": "https://www.reuters.com/article/brief-collegium-reports-q4-loss-per-shar/brief-collegium-reports-q4-loss-per-share-0-54-idUSASB0C998",
    "ord_in_thread": 0,
    "title": "BRIEF-Collegium Reports Q4 Loss Per Share $0.54",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 7, 2018 / 9:15 PM / in 9 minutes BRIEF-Collegium Reports Q4 Loss Per Share $0.54 Reuters Staff March 7 (Reuters) - Collegium Pharmaceutical Inc: * COLLEGIUM REPORTS FOURTH QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE * Q4 LOSS PER SHARE $0.54 * COLLEGIUM PHARMACEUTICAL - BELIEVE EXISTING CASH RESOURCES WILL FUND OPERATING EXPENSES, DEBT SERVICE AND CAPEX REQUIREMENTS INTO 2020  ",
    "published": "2018-03-07T23:12:00.000+02:00",
    "crawled": "2018-03-07T23:33:26.013+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "minute",
        "report",
        "q4",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "march",
        "reuters",
        "collegium",
        "pharmaceutical",
        "inc",
        "collegium",
        "report",
        "fourth",
        "quarter",
        "financial",
        "result",
        "provides",
        "corporate",
        "update",
        "q4",
        "loss",
        "per",
        "share",
        "collegium",
        "pharmaceutical",
        "believe",
        "existing",
        "cash",
        "resource",
        "fund",
        "operating",
        "expense",
        "debt",
        "service",
        "capex",
        "requirement"
    ]
}